Evaluation of the Strength of Handgrip in Patients With Pulmonary Artery Hypertension
1 other identifier
interventional
55
1 country
1
Brief Summary
Our study aims to investigate the changes in muscle strength and muscle mass in PAH patients compared to healthy individuals and determine its effects on prognosis. Further categorization of PAH patients based on their NYHA class will help determine if their handgrip strength decreases while progressing from NYHA class 1 to 4. This in turn allows us to examine if the handgrip test can be considered as an alternative to a 6-minute walking test (6MWT). The Jamar Hydraulic Hand Dynamometer device in our hospital is used for measuring the handgrip strength test. The data of the included subjects in this study are obtained and recorded from the existing files. Also, the handgrip strength test data will be recorded after the investigation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 28, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedJuly 7, 2022
July 1, 2022
2.7 years
June 28, 2022
July 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the strength of handgrip in patients with pulmonary artery hypertension
Investigate and evaluate of the strength of handgrip in patients with pulmonary artery hypertension with hand dynamometer compared to healthy individuals.
Baseline
Secondary Outcomes (1)
Evaluation of the strength of handgrip in patients with pulmonary artery hypertension
Baseline
Study Arms (2)
Pulmonary Hypertension
ACTIVE COMPARATORHealthy Control
ACTIVE COMPARATORInterventions
The Jamar Hydraulic Hand Dynamometer device is used for measuring the handgrip strength test
Eligibility Criteria
You may qualify if:
- Pulmonary Hypertension Group:
- Diagnosed with Pulmonary Hypertension and attending the clinic for follow-ups.
- Older than 5 years.
- Healthy Control Group
- Individuals without any known diseases, structural Cardiac anomalies, familial history of heart diseases and sudden death.
- Older than 5 years.
You may not qualify if:
- Volunteers' Rejection Criteria:
- Younger than 5 years.
- Mental state disorders which will cause inaccuracies in the study's
- i. Volunteers' Dismissal Criteria:
- Inadaptation to the study's steps.
- If subjects become reluctant to continue with the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University School of Medicine
Ankara, 06560, Turkey (Türkiye)
Related Publications (7)
Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, Budts W, D'Alto M, Gatzoulis MA, Hasan BS, Kozlik-Feldmann R, Kumar RK, Lammers AE, Latus H, Michel-Behnke I, Miera O, Morrell NW, Pieles G, Quandt D, Sallmon H, Schranz D, Tran-Lundmark K, Tulloh RMR, Warnecke G, Wahlander H, Weber SC, Zartner P. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019 Sep;38(9):879-901. doi: 10.1016/j.healun.2019.06.022. Epub 2019 Jun 21.
PMID: 31495407BACKGROUNDKula S, Pektas A. A review of pediatric pulmonary hypertension with new guidelines. Turk J Med Sci. 2017 Apr 18;47(2):375-380. doi: 10.3906/sag-1605-172.
PMID: 28425226BACKGROUNDDi Rienzo A, Felicetti L, Novelletto A, Forteleoni G, Colombo B. Frequency and types of deletional alpha+-thalassemia in northern Sardinia. Hum Genet. 1985;71(2):147-9. doi: 10.1007/BF00283371.
PMID: 2995236BACKGROUNDNeidenbach RC, Oberhoffer R, Pieper L, Freilinger S, Ewert P, Kaemmerer H, Nagdyman N, Hager A, Muller J. The value of hand grip strength (HGS) as a diagnostic and prognostic biomarker in congenital heart disease. Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S187-S197. doi: 10.21037/cdt.2019.09.16.
PMID: 31737527BACKGROUNDMathiowetz V, Wiemer DM, Federman SM. Grip and pinch strength: norms for 6- to 19-year-olds. Am J Occup Ther. 1986 Oct;40(10):705-11. doi: 10.5014/ajot.40.10.705.
PMID: 3777107BACKGROUNDHager-Ross C, Rosblad B. Norms for grip strength in children aged 4-16 years. Acta Paediatr. 2002;91(6):617-25. doi: 10.1080/080352502760068990.
PMID: 12162590BACKGROUNDPloegmakers JJ, Hepping AM, Geertzen JH, Bulstra SK, Stevens M. Grip strength is strongly associated with height, weight and gender in childhood: a cross sectional study of 2241 children and adolescents providing reference values. J Physiother. 2013 Dec;59(4):255-61. doi: 10.1016/S1836-9553(13)70202-9.
PMID: 24287219BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D, Professor
Study Record Dates
First Submitted
June 28, 2022
First Posted
July 7, 2022
Study Start
September 1, 2020
Primary Completion
May 1, 2023
Study Completion
June 1, 2023
Last Updated
July 7, 2022
Record last verified: 2022-07